| Logo | Name | Σ | ||
|---|---|---|---|---|
 | Moderna Our mission is to deliver the greatest possible impact to people through mRNA medicines. At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using … Sectors: | 713 | 558 | 84 |
 | Kurma Partners Our Vision : We have High Standards - We Build Companies - We have Impact Kurma Partners is a key European venture capital group specialized in healthcare, with €470 million under management, with two dedicated franchises : Kurma Biofund focused on therapeutic (current active fund KBIII) and Kurma Diagnostics focused on diagnostic and digital health (current active fund Kurma Dx2). Biotechnology, Lifesciences, Drug Development, Technology transfer, Rare diseases, Digital Healh, Diagnostics, and Medtech Sectors: | 154 | 99 | 37 |
 | Gouvernement The official account of the French Government Follow Government news on this page in real time, including practical information, measures, numbers, results, and the profiles of economic players ! | 2316 | 1781 | 661 |
 | Amundi Trust must be earned Amundi, the leading European asset manager, ranking among the top 10 global players* , offers its 100 million clients - retail, institutional and corporate - a complete range of savings and investment solutions in active and passive management, in traditional or real assets. This offering is enhanced with IT tools and services to cover the entire savings value chain. A subsidiary of the Crédit Agricole group and listed on the stock exchange, Amundi currently manages more than €2.15 trillion of assets**. With its six international investment hubs***, financial and extra-financial research capabilities and long-standing commitment to … Sectors: | 948 | 641 | 124 |
 | Bpifrance [Automatic translation follows] Account of Bpifrance, the Public Investment Bank. Bpifrance, a public investment bank, supports companies from seed to stock market listing, from credit to equity. A privileged contact, Bpifrance offers financing or investment solutions in each region that are adapted to each stage of a company's life. A partner bank for entrepreneurs, Bpifrance provides them with long-term support to support their growth and competitiveness. The teams are at the heart of the regions, throughout the country, through more than 50 regional locations. Financing of SMEs, Business Creation, International Development, Investment, Creation/Transmission, Innovation, Support, Acceleration, and Export Guarantee Sectors: | 12637 | 9606 | 1604 |
 | Sofinnova Partners Sofinnova Partners is a leading European VC firm in life sciences, specializing in healthcare and sustainability. Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise. Sofinnova Partners is a hands-on company builder across the entire value chain of life sciences investments, from seed to later-stage. The firm actively partners with ambitious entrepreneurs as a lead or cornerstone investor to develop transformative innovations that have the potential … | 404 | 205 | 216 |
 | Institut Curie [Automatic translation follows] Together, let's beat cancer A foundation recognized as being of public utility, the Institut Curie combines one of the largest European cancer research centers and two cutting-edge hospitals. Founded in 1909 on a model designed by Marie Curie and still avant-garde, "from fundamental research to innovative care", the Institut Curie brings together 3,000 researchers, doctors, caregivers, technicians and administrators. Care The Institut Curie Hospital Group is a reference center for breast cancer, eye tumors and pediatric cancers in particular. Research To advance the prevention, diagnosis and treatment of cancers, biologists, chemists, physicists, bioinformaticians and doctors are mobilizing … Sectors: | 967 | 791 | 145 |
 | Merck Group This channel is not intended for U.S. and Canadian visitors. Merck operates in the U.S. and Canada as EMD Serono in Healthcare, MilliporeSigma in Life Science and EMD Electronics in Electronics. An unaffiliated and unrelated company, Merck & Co., Inc., Kenilworth, NJ, US holds the rights in the trademark MERCK in the U.S. and Canada. _______________________________ We are Merck, a leading global science and technology company headquartered in Germany. We are curious explorers, courageous pioneers, and ingenious inventors. Our colleagues across the globe love innovating with science and technology to enrich people’s lives with our solutions in Life Science, Healthcare, … Tags: DAX30 Sectors: | 1512 | 895 | 337 |
 | Technofounders We are entrepreneurs turning technology into impactful ventures. 🚀 #venturebuilder #impact We create, finance and accelerate industrial deeptech ventures in Europe. 👉 De-risking early-stage investment in deeptech 🎯 Developing the most effective ecosystem to create and accelerate a deeptech startup 👁 Always looking for entrepreneurs, academic partners and investors The studio was founded in 2014 by Pierre, Yves and Olivier, and later joined by Sébastien, our investment specialist, creating a partnering team of four science and technology enthusiasts. Today, we bring together hundreds of entrepreneurs, research scientists and investors around 6 sectors : agriculture, health, green chemistry, security and space, … Sectors: | 92 | 27 | 71 |
 | Sanofi We are Sanofi, an innovative global healthcare company. We chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Interactions with this account must comply with the Terms: https://bit.ly/sanofi-terms vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare Tags: CAC40 Sectors: | 3561 | 2658 | 836 |
 | Grand Paris Express [Automatic translation follows] The Société du Grand Paris (SGP) is a public industrial and commercial institution whose mission is to create the new automatic metro of Greater Paris, the Grand Paris Express. The SGP is responsible for the design and development of the overall plan and infrastructure projects making up the Greater Paris public transport network. It must also ensure its implementation, which includes in particular: > the construction of lines, structures and fixed installations, > the construction and development of stations, including interconnections, > the acquisition of rolling stock designed to run on these infrastructures. Sectors: | 475 | 490 | 175 |
 | Seventure Partners We actively fund innovative companies within the two evolving fields of Digital technologies and Life sciences. Seventure Partners is a long term equity investor that actively supports innovative companies aiming at generating positive impacts on Humankind, Society, Sustainability and the Planet. With €950m net commitments under management as of the end of 2022, Seventure is a leading venture capital firm in Europe investing since 1997 in innovative businesses with high growth potential in 2 main areas: Life sciences (Biotech, Health & digital Health, Nutrition, Foodtech, Blue Economy, Aquaculture, Animal & Agriculture, Sport & Wellness ...) with a specific interest for … Sectors: | 313 | 186 | 101 |
 | Région Ile de France The Paris Region is a major business and techno hub in Europe. Standing at the crossroads of European and worldwide trade, the Paris Region is France's leading economic region. It represents 31% of French GDP. Consisting of 8 départements and 1,280 municipalities, the Paris Region hosts the largest population of french Regions : 12.5 million inhabitants, that is younger than the national average. As Europe’s leading employment area, it boasts a highly qualified workforce : 33% of French executives. The Paris Region hosts 22% of France’s universities, 25% of its engineering schooland 20% of its business schools. Invest in Paris … Sectors: | 5006 | 4101 | 695 |
 | Kamet Ventures We are a venture inventor and builder focused on building breakthrough companies in HealthTech, InsurTech & Mobility Kamet Ventures was created in 2016 as a breakthrough model in innovation. We seek to identify the world's most talented entrepreneurs and partner with them to build the next generation of ground-breaking technology companies. With offices across Paris, London and Tel Aviv, we create companies that are geared to improve, enrich and prolong our lives. Technology/Digital, start-up, Incubator, InsurTech, venture capital, healthtech, and insurance | 63 | 14 | 48 |
 | Medicen Paris Region Innovation for Health Founded in 2005, the Medicen Paris Region global competitiveness cluster aims to position the Paris Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies, thus enabling it to become one of the global centres for translational medicine. Medicen Paris Region’s partnership approach is based on the concept of economic value creation in the Paris Region stimulated by innovation, which forms the very basis of the creation of competitiveness clusters and sets three main priorities: developing growth and employment in profitable markets in a successful dynamic relationship between YICs/SMEs, large firms and … Sectors: | 652 | 392 | 395 |
 | Eurobiomed The service catalyst for the community of healthcare innovators in the south of France. Created in 2005, the Eurobiomed competitiveness cluster helps to unite and position the healthcare ecosystem of the Provence-Alpes-Côte-d'Azur and Occitanie/Pyrénées-Méditerranée regions at the cutting edge of innovation. Its aim is to foster the growth and projects of innovative healthcare companies in the region. From immunology and dermatology to neurology, oncology and digital health, Eurobiomed supports French and European public economic development strategies, helping to position its members as European champions and anchor France among the world leaders in healthcare innovation. Eurobiomed brings together all healthcare players, … Sectors: | 421 | 249 | 194 |
 | iBionext VENTURE BUILDER & GROWTH FUND Building and financing healthtech start-ups from creation to growth to transform innovation into products. OUR ACHIEVEMENTS - IBIONEXT IN NUMBERS 9 companies created 600M+ Euros raised collectively by iBionext and its companies since 2012 370+ highly qualified jobs created OUR APPROACH Spot: We provide a structural ecosystem to source, mature, finance and build innovative technologies. Boost : We gather experimented professionals to turn disruptive ideas into start-ups and lead their financing. Grow: We support the growth of our companies to maximise their value and build international champions. Biotech, Medtech, Growth Capital, deeptech, AI, and e-Health Sectors: | 64 | 33 | 6 |
 | Greater Paris University Hospitals - AP-HP Nous soignons et innovons 365 jours par an. AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital. Its 39 hospitals treat 8 million people every year: in consultation, emergency, during scheduled or home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area: 100.000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers – work there. Toutes les spécialités médicales de la néonatologie à la gériatrie en passant par … Sectors: | 2201 | 1511 | 153 |
 | Genopole Genopole, biocluster leader en France, Vivre l'innovation Created in 1998, Genopole® has a threefold mission: - develop a high-level research campus in genomics and post-genomics, focused on gene therapy in collaboration with the University Evry-Paris Saclay, - encourage the start-up and foster the development of biotech companies in the Paris region by providing personalized advice and support, including financial assistance - create a biopark in Evry-Courcouronnes in collaboration with the research campus. biocluster, research campus - academical laboratories, biotech companies, university, life sciences companies, Infrastructure - Shared-use technology platforms, and Biotherapy Sectors: | 324 | 168 | 162 |
 | France Biotech Entrepreneurs in HealthTech Created in 1997, the association is the French non-profit organization that brings together the country's leading innovative health compagnies and their expert partners (investors, lawyers, research institutes, cluster, etc...). Its core mission is to promote health innovation in France and help the sector's start-up companies and SMEs to become tomorrow's leaders able to rapidly develop new therapeutic solutions. Our Missions: To support innovative start-ups and SMEs of the HealthTech industry (biotech, medtech, digital health, big data) by tackling four major issues: - Financial: encourage investment in health innovation - Tax: ensure fiscal stability - Administrative and regulatory: … Sectors: | 880 | 513 | 530 |
 | Ouest-France [Automatic translation follows] 🗞Ouest-France, the leading French daily newspaper! Every day, over 600,000 copies in Normandy, Brittany & Pays de la Loire OUEST-FRANCE Company Founder of the Editorial Committee François Régis Hutin Chairman of the Board Louis Échelard - Director of Publication The associative status: Since the extraordinary general meeting of April 9, 1990, S.A. Ouest-France has been part of a non-profit association under the 1901 law, the "Association for the support of the principles of humanist democracy", chaired by Jacques Duquesne. Location: 58 editorial offices in the 14 departments in Brittany, Lower Normandy and Pays de la Loire, as … Sectors: | 4242 | 3492 | 455 |
 | CEA The CEA is the French Alternative Energies and Atomic Energy Commission ("Commissariat à l'énergie atomique et aux énergies alternatives"). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and … Sectors: | 2793 | 1776 | 357 |
 | Edmond de Rothschild We never forget that you entrust us with what you hold most precious. Edmond de Rothschild is an investment house – guided by the belief that the money entrusted to us is the most valuable thing people possess and that it can achieve a lot. When invested in the real economy and reflecting everyone's convictions, it can yield financial, societal, and personal returns. It has the power to create something useful. Wealth, when invested, can shape the future world and improve the present one. It is this philosophy that has shaped a financial tradition to which many have tried and … | 222 | 166 | 14 |
 | MSD At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse … Sectors: | 2128 | 1875 | 191 |
 | Elaia European venture capital firm focused on digital & deep tech startups, from early stage to growth development. European venture capital firm focused on digital and deep tech startups, from early stage to growth development. We back tech disruptors – such as Mirakl, Criteo, Ornikar, Shift Technologies and Aqemia. Learn more: www.elaia.com Sectors: | 466 | 325 | 167 |
 | Gustave Roussy [Automatic translation follows] Prevention / Care / Research / Education, at the service of patients with #cancer. Gustave Roussy, the leading cancer center in Europe, the 4th best cancer hospital in the world, is a global center of expertise against cancer, at the service of patients. It brings together 3,100 professionals whose missions are prevention, care, research and education on two sites: in Villejuif and Chevilly-Larue (Greater Paris). A private institution of collective interest, Gustave Roussy is authorized to receive donations and legacies. Cancerology, care, research, and education Sectors: | 481 | 392 | 77 |
 | La French Tech Paris-Saclay Une capitale French Tech à l'écoute des start-up deeptech de Paris-Saclay « La French Tech » : c’est le mouvement français des startups. Un écosystème unique qui réunit des startups (donc), mais aussi des investisseurs, des décideurs et des community builders. La French Tech Paris-Saclay Capitale labélisée en IdF au côté de la capitale French Tech Grand Paris. Sectors: | 453 | 162 | 336 |
 | Bristol Myers Squibb At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experience. Join us and pursue innovative ideas alongside some of the brightest minds in biopharma, collaborating with a team rich in diversity of experiences, and perspectives. We have built a sustainable pipeline of potential therapies and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient, at the right time, to achieve the best outcome. Whether in a scientific, business or supporting function, … Sectors: | 1682 | 1089 | 129 |
 | La French Tech La French Tech désigne tous les acteurs de l’écosystème de start-up françaises, soutenus par la Mission French Tech. 🇫🇷 La French Tech est la marque déployée par l’Etat français qui représente l’écosystème de 25 000 start-up françaises et de tous les acteurs qui gravitent autour (fonds d’investissement, associations, acteurs publiques, etc.), soutenus par la Mission French Tech (administration rattachée à la Direction Générale des Entreprises, au sein du ministère de l’Economie, des Finances et de l'Industrie). Elle a pour mission d’accompagner le développement de l’écosystème French Tech, mouvement français des start-up technologiques innovantes, dans la lignée des priorités gouvernementales, à … Sectors: | 4026 | 2363 | 1661 |
 | PariSanté Campus [Automatic translation follows] PariSanté Campus, here digital health grows! PariSanté Campus aims to create a coherent and synergistic group of public and private operators, with the ambition of structuring a research and innovation sector in digital health with global influence. This group will be set up on the site of the former Val-de-Grâce military training hospital, and to create a network of partnerships in the Paris region, nationally and internationally. The group will be financed by unprecedented investments from the recovery plan, and will aim to be a major vector for the creation of medical-scientific, but also economic, value. Based … | 378 | 198 | 144 |
 | Astellas Pharma Astellas Pharma is a pharmaceutical company conducting business in approximately 70 countries around the world. At Astellas, we strive to be a cutting-edge, value-driven life science innovator. This means working at the forefront of healthcare change to turn innovative science into the best outcomes for patients. Operating in approximately 70 countries with more than 14,000 employees, we are relentless in our pursuit of scientific progress and in tackling unmet medical needs. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines Pharmaceuticals and 医薬品 Sectors: | 133 | 97 | 27 |
 | Business France Business France is the national agency for the internationalization of the French economy. It is responsible for the international development of companies and their exports, as well as prospecting for and welcoming international investments in France. It promotes the attractiveness and business image of France, its companies and its territories. It manages and develops the V.I.E (Volontariat International en Entreprise). Created on January 1, 2015, Business France is a merger of UBIFRANCE and the AFII (French Agency for International Investments). Business France has 1,500 employees located in France and in 70 countries. It relies on a network of public and … Sectors: | 5405 | 3303 | 2389 |
 | IncubAlliance Incubateur des start-up tech et deeptech du cluster Paris-Saclay Accompagnement de projets de création d'entreprises technologiques innovants Entrepreneurship, Consulting, Technology, Public R&D, Innovation, and Investment | 189 | 62 | 142 |
 | Takeda Better Health, Brighter Future We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our … Sectors: | 1011 | 718 | 265 |
 | Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in 88 countries. For more information, visit ipsen.com. Pauta exclusiva para México: Clave de Autorización COFEPRIS: 243300201B1962 CONSULTE A SU MÉDICO. Pharmaceuticals, Specialty care: oncology, neuroscience, endocrinology, Research: peptides, toxins, … Sectors: | 404 | 347 | 58 |
 | SATT Paris-Saclay [Automatic translation follows] Innovation with confidence Created in 2014 and resulting from the "Investments for the Future" Program, SATT Paris-Saclay is the Technology Transfer Acceleration Company of the Paris-Saclay Cluster. A common player for both entities - Université Paris-Saclay and Institut Polytechnique de Paris - SATT has an investment capacity of 66 million euros over 10 years to finance and support the development of research work from the region and technology transfer to the markets. Innovation, Technology Transfer, and Start-up Tags: SATT Network Sectors: | 243 | 113 | 159 |
 | Linksium Detecting promising #deeptech and fostering the creation of #startups with Grenoble Alpes IP inside . Linksium, Société d’Accélération du Transfert de Technologies (SATT) de Grenoble Alpes détecte projets prometteurs issus de la recherche publique, finance et accompagne la création de startups #deeptech. Detecting promising technologies, funding and fostering the creation of deeptech #startups in the French Alps area. Technology transfert, Startups building, deeptech, venture capital, Research & development , and R&D Tags: SATT Network | 375 | 123 | 228 |
 | GSK We are uniting science, technology and talent to get ahead of disease together. Our community guidelines: https://gsk.to/socialmedia Pharmaceutical products and Vaccines Sectors: | 1120 | 735 | 402 |
 | Roche Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, … Sectors: | 1611 | 1460 | 60 |
Biotechnology